Item 2. Unregistered Sales of Equity Securities
Item 2. Unregistered Sales of Equi ty Securities and Use of Proceeds.
(a) Sales of Unregistered Securities
None.
(b) Use of Proceeds from Public Offering of Common Stock
On June 26, 2019, our Registration Statements on Form S-1 (File Nos. 333-231759 and 333-232376) relating to our IPO were declared effective by the SEC. There has been no material change in the planned use of proceeds from our IPO from those that were described in the final prospectus filed pursuant to Rule 424(b) under the Securities Act and other periodic reports previously filed with the SEC.
(c) Issuer Purchases of Company Equity Securities
The following table reflects share repurchases of our common stock for the three months ended September 30, 2021.
Period
Total Number
of Shares
Purchased
Average Price
Paid
per Share
Total Number
of Shares
Purchased as Part of
Publicly
Announced
Plans or
Programs (1)
Approximate
Dollar Value of
Shares That
May Yet Be
Purchased
Under the
Plans or
Programs (1)
July 1, 2021 to July 31, 2021
—
$
—
—
$
144,690,507
August 1, 2021 to August 31, 2021
1,721,523
49.60
1,721,523
59,311,397
September 1, 2021 to September 30, 2021
1,190,870
49.81
1,190,870
—
Total
2,912,393
2,912,393
$
—
(1) On May 11, 2021, the Board of Directors of BridgeBio authorized and approved a stock repurchase program pursuant to which we may purchase up to $150 million of our outstanding common stock. Stock repurchases under the program may be made from time to time, in the open market, in privately negotiated transactions and otherwise, at the discretion of management and in accordance with applicable federal securities laws, including Rule 10b-18 of the Securities Exchange Act of 1934, as amended, and other applicable legal requirements. The timing, pricing and amounts of these repurchases will depend on a number of factors, including the market price of our common stock and general market and economic conditions. The stock repurchase program does not obligate us to repurchase any dollar amount or number of shares, and the program may be suspended or discontinued at any time.
53
Item 3. Defaults Upon Senior Securities.
None.
Item 4. Mine Saf ety Disclosures.
Not applicable.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.